Medici di Diagnostica in Israele — Pagina 2

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Pnina Langevich leads the National Center for Rheumatology at Sheba Medical Center. She is a former Vice President of the World Association of Rheumatologists. Forbes Israel has repeatedly named her among the country’s top doctors. Dr. Langevich treats severe cases of lupus, scleroderma, and rheumatoid arthritis.

• Served for 12 years as Vice President of the World Association of Rheumatologists.
• Functions as the Editor–in–Chief of the international medical journal Lupus.
• Specializes in managing treatment–resistant autoimmune and joint diseases.
• Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center in Israel. He is a primary pioneer of robotic and laparoscopic urologic surgery. He specializes in treating complex cancers of the kidney, prostate, and bladder. Dr. Dotan leads the Israeli Uro-Oncology Society and holds a PhD in Genetics.

• Completed a specialized uro-oncology fellowship at Memorial Sloan Kettering in New York.
• Performs robotic radical nephrectomy and da Vinci robotic prostatectomy.
• Authored over 50 scientific publications on advanced urologic cancer treatments.
• Works at Sheba Medical Center, ranked 7th best hospital globally by Newsweek.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Il medico dirige il Centro di Melanoma e Immunoterapia del Cancro presso il Centro Medico Hadassah, concentrandosi sulla ricerca innovativa e sul trattamento dei pazienti. Specializzandosi nello studio della famiglia dei recettori SLAM, il medico è in prima linea nella ricerca sulla risposta immunitaria anti-cancro.<\/p>

Coinvolto nel trattamento dei pazienti con melanoma con nuove immunoterapie, il medico lavora con un team di clinici e ricercatori. Questa collaborazione fornisce accesso immediato ai dati clinici e ai tessuti derivati dai pazienti, migliorando gli sforzi di ricerca traslazionale.<\/p>

Il medico è un dermatologo-venereologo esperto e pioniere della chirurgia micrografica in Israele, con oltre 30 anni di esperienza professionale. Specializzandosi nel metodo MOHS, il medico ha contribuito significativamente al campo della dermatologia attraverso tecniche innovative nella rimozione strato per strato delle oncopatologie cutanee.<\/p>

Laureato presso l'Università Medica di Tel Aviv e ha proseguito l'educazione medica presso il Centro Oncologico di Houston, USA. Il medico è un membro attivo delle comunità dermatologiche europee, israeliane e americane e ha scritto circa 100 opere scientifiche e mediche.<\/p>

Il medico è un oncologo altamente esperto con un focus sul trattamento e la gestione del cancro. Con anni di pratica dedicata, il medico ha contribuito in modo significativo ai progressi in oncologia, implementando terapie all'avanguardia e partecipando a ricerche volte a migliorare i risultati dei pazienti. Il medico è riconosciuto per la sua leadership all'interno della comunità oncologica, avendo ricoperto ruoli chiave che guidano l'innovazione e la cura di qualità nel trattamento del cancro. La loro esperienza clinica è completata da un impegno per la cura centrata sul paziente e lo sviluppo professionale continuo.<\/p>